Source: BioPharma-Reporter

ABC Laboratories: EAG expands biopharma analysis capabilities in 'major investment'

EAG has further invested in ABC Laboratories' capacity and analytical capabilities in order to help meet demand for high-end biopharmaceutical analysis.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more